SMTL ID : 8d6f.1 (1 other biounit)

Crystal Structure of Human Myt1 Kinase domain Bounded with Eph receptor inhibitor / compound 41

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.49 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 5 residues within 4Å: Chain A: R.95, G.96, P.97, K.98, D.99 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.98, A:D.99

1 x QG5: (1M)-2-amino-1-(5-hydroxy-2-methylphenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide(Non-covalent)

QG5.2: 17 residues within 4Å: Chain A: L.65, G.66, Y.70, V.73, A.86, K.88, E.106, H.110, V.120, T.136, E.137, L.138, C.139, G.140, F.189, G.199, D.200 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.73, A:V.73, A:A.86, A:K.88, A:T.136, A:F.189 Hydrogen bonds: A:H.110, A:T.136, A:E.137, A:C.139, A:C.139, A:D.200 Water bridges: A:F.201 pi-Cation interactions: A:K.88

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Szychowski, J. et al., Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306. J.Med.Chem. (2022)

Release Date

2022-07-27

Peptides

Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase

Related Entries With Identical Sequence